itric oxide (NO) plays a central role in the regulation of cardiovascular homeostasis and is involved in the regulation of vascular tone and cardiac contractility as well as gene expression and cell proliferation. Furthermore, NO modulates renin secretion and salt and fluid reabsorption in the kidney. 1 Three isoforms of NO synthase (NOS) have been identified, the neuronal NOS (nNOS or NOS I), the inducible NOS (iNOS or NOS II), and the endothelial NOS (eNOS or NOS III). While all of these enzymes potentially affect blood pressure, only eNOSdeficient mice are hypertensive. 2, 3 Although nNOS is expressed in cardiac myocytes, 4, 5 as well as in vascular smooth muscle cells, 6 -8 relatively little is known about the role played by nNOS-derived NO in cardiovascular homeostasis. Both pro-and antihypertensive actions have been attributed to nNOS, and selective inhibitors of this isoform have been reported to normalize blood pressure, 9 as well as to attenuate flow-induced vasodilatation in eNOS Ϫ/Ϫ mice. 8 The regulation of nNOS activity, like that of eNOS, is determined by phosphorylation of the enzyme as well as by its association with a number of regulatory proteins. 10 One protein that associates with nNOS in human embryonic kidney (HEK293) cells and is reported to play a major role in regulating the activity of the Ca 2ϩ -dependent enzyme, is the plasma membrane Ca 2ϩ /calmodulin-dependent Ca 2ϩ -ATPase (PMCA). 11 The ATPase binds to nNOS via an interaction between its carboxyl terminus and the PDZ domain of nNOS. Increasing expression of the PMCA4b isoform markedly attenuates NO synthesis by nNOS, an effect not observed in cells overexpressing a mutant PMCA that was devoid of Ca 2ϩ -transporting activity. 11 Thus, it appears that the PCMA4b, by decreasing the concentration of Ca 2ϩ in the local vicinity of nNOS, can reduce NO and subsequently cGMP production.
In this issue of Circulation Research, Gros et al 12 investigated the relationship between PMCA4b and nNOS by generating doxycycline-responsive transgenic mice that selectively overexpress the human PMCA4b (hPMCA4b) in arterial smooth muscle cells. The authors found that a 2-fold increase in hPMCA4b expression had a subtle effect on thapsigargin-insensitive Ca 2ϩ -dependent ATPase activity but no significant effect on basal [Ca 2ϩ ] i or Ca 2ϩ sensitivity. The authors' most impressive finding was that hPMCA4b expression was accompanied by a markedly enhanced myogenic response in isolated mesenteric arteries as well as by increased contractile responses to phenylephrine and prostaglandin F2␣ but not to KCl. Global NOS inhibition using N -nitro-L-arginine and selective inhibition of nNOS with N -propyl-L-arginine did not affect the myogenic response in mesenteric arteries from hPMCA4b-expressing mice but significantly attenuated responses in non-hPMCA4bexpressing littermates. Since overexpression of the Ca 2ϩ -ATPase and nNOS inhibition elicited similar effects, the authors suggest that the small increase in Ca 2ϩ -dependent ATPase activity in the hPMCA4b-overexpressing mice was sufficient to deplete Ca 2ϩ from nNOS and to inhibit its activity, thus alleviating the intrinsic functional inhibition of nNOS on contractile responses. There is at least circumstantial evidence to support this conclusion since cGMP levels were lower in aortic smooth muscle cells from hPMCA4boverexpressing mice. As mentioned above, this is not the first report suggesting that nNOS could play a significant role in the regulation of vascular tone, but it provides compelling evidence that NO generated by nNOS can affect the myogenic response.
The myogenic response is a main determinant of vascular tone in situ and consistent with the effect observed on contraction, Gros et al 12 report that hPMCA4b-expressing mice have higher systolic and diastolic blood pressures than their hPMCA4b-deficient littermates. Blood pressure was normalized by treatment with doxycycline, which prevented hPMCA4b expression. However, if the enhanced expression of hPMCA4b increases blood pressure via its inhibitory effect on nNOS activity, why do nNOS knockout animals not demonstrate a manifest hypertension? The most likely explanation is that additional mechanisms are activated to compensate for the global lack of nNOS in these animals.
Overexpression of one constituent of the Ca 2ϩ homeostatic machinery would be expected to have distinct consequences on [Ca 2ϩ ] i . However, in cultured aortic smooth muscle cells isolated from hPMCA4b-deficient and hPMCA4b-expressing mice, Gros et al 12 found no difference in basal [Ca 2ϩ ] i . Notably, in these cells, the expression of hPMCA4b was associated with a decrease in the expression of the murine PMCA1 and PMCA4 as well as an increase in SERCA2a, SERCA2b, and the inositol 1,4,5-trisphosphate-activated Ca 2ϩ channel (IP3R) mRNA. Thus 12 in cultured smooth muscle cells were more marked than those observed in freshly isolated aortae, similar alterations in SERCA and IP3R expression have previously been reported in rat endothelial cells overexpressing PMCA1. 13 While the increased myogenic response was the most pronounced effect of hPMCA4b overexpression, the molecular mechanisms underlying this response remain to be investigated in detail. Given the reported compensatory increase in SERCA and IP3R mRNA expression, it is possible that the enhanced release of intracellular Ca 2ϩ by increases in transmural pressure as well as by phenylephrine could account for the effects observed. 12 However, data gathered over the last 5 to 8 years have convincingly shown a link between vascular 20-hydroxyeicosatetraenoic acid (20-HETE) generation and myogenic responses in renal, cerebral, and mesenteric arteries. 14 -16 20-HETE is endogenously produced by smooth muscle cells after an increase in [Ca 2ϩ ] i , and, once formed, increases smooth muscle tone (and enhances sensitivity to phenylephrine) by inhibiting large conductance Ca 2ϩ -dependent K ϩ channels inducing depolarization and contraction (see recent reviews [17] [18] [19] ). This effect is related to the activation of L-type Ca 2ϩ channels, 20 as well as the activation of the Rho kinase and the phosphorylation of myosin light chain. 21 Endothelium-derived factors are able to modulate myogenic contraction and at least part of their action can be attributed to interference with the formation and actions of 20-HETE. For example, NO may modulate the formation of 20-HETE by binding to and inactivating the cytochrome P450 enzyme that generates this eicosanoid. Indeed, the NO-mediated inhibition of 20-HETE formation has been proposed to account for the natriuretic and diuretic actions of NO, 22 as well as the cGMP-independent relaxant effects of NO in renal and cerebral arteries. 23, 24 While it has been generally assumed that the NO that modulates 20-HETE generation is derived from endothelial cells, it is just as likely that NO derived from nNOS in vascular smooth muscle cells can influence the same cellular processes. It will therefore be interesting to determine whether the overexpression of hPMCA4b is linked to changes in 20-HETE levels, Rho kinase activity, and myosin light chain phosphorylation, and whether the reported increase in 20-HETE production in mesenteric arteries from spontaneously hypertensive rats 25 is directly related to an increase in PMCA expression 26 and a decrease in nNOS-derived NO production (Figure) . For such a signaling cascade to be functional, it is essential that Ca 2ϩ levels are tightly regulated in specific intracellular microdomains and that the extrusion of Ca 2ϩ by the PMCA, which are known to be concentrated with nNOS in caveolae, does not affect Ca 2ϩ signaling process required to initiate 20-HETE production and contraction.
